Compare SMTI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMTI | STXS |
|---|---|---|
| Founded | 1982 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.9M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | SMTI | STXS |
|---|---|---|
| Price | $20.30 | $1.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $41.00 | $4.00 |
| AVG Volume (30 Days) | 60.3K | ★ 516.7K |
| Earning Date | 03-24-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $101,877,532.00 | $30,075,000.00 |
| Revenue This Year | $21.60 | $24.21 |
| Revenue Next Year | $16.70 | $29.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 30.52 | 19.62 |
| 52 Week Low | $18.90 | $1.54 |
| 52 Week High | $36.60 | $3.59 |
| Indicator | SMTI | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 36.28 | 26.28 |
| Support Level | $20.12 | $2.18 |
| Resistance Level | $22.43 | $2.82 |
| Average True Range (ATR) | 1.25 | 0.13 |
| MACD | -0.17 | -0.07 |
| Stochastic Oscillator | 0.00 | 0.00 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.